Hansa Biopharma AB Share Price Deutsche Boerse AG
Equities
24H
SE0002148817
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.37 EUR | -3.82% | +2.06% | +37.44% |
05-21 | Hansa Biopharma to Present Data At 2024 American Transplant Congress Annual Meeting | CI |
04-18 | Transcript : Hansa Biopharma AB, Q1 2024 Earnings Call, Apr 18, 2024 |
Sales 2024 * | 239M 22.65M 20.85M 1.77B | Sales 2025 * | 343M 32.44M 29.86M 2.54B | Capitalization | 2.52B 239M 220M 18.7B |
---|---|---|---|---|---|
Net income 2024 * | -735M -69.59M -64.05M -5.45B | Net income 2025 * | -712M -67.41M -62.05M -5.28B | EV / Sales 2024 * | 12.5 x |
Net Debt 2024 * | 474M 44.88M 41.31M 3.52B | Net Debt 2025 * | 733M 69.44M 63.91M 5.44B | EV / Sales 2025 * | 9.5 x |
P/E ratio 2024 * |
-3.46
x | P/E ratio 2025 * |
-4.11
x | Employees | 166 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.64% |
Latest transcript on Hansa Biopharma AB
1 day | -3.82% | ||
1 week | +2.06% | ||
Current month | +40.42% | ||
1 month | +46.39% | ||
3 months | +21.14% | ||
6 months | +55.30% | ||
Current year | +37.44% |
Managers | Title | Age | Since |
---|---|---|---|
Søren Tulstrup
CEO | Chief Executive Officer | 59 | 19/03/18 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 11-30 |
Achim Kaufhold
CTO | Chief Tech/Sci/R&D Officer | 66 | 28/05/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 28/05/18 | |
Peter Nicklin
CHM | Chairman | 61 | 29/06/22 |
Mats Blom
BRD | Director/Board Member | 59 | 21/05/19 |
Date | Price | Change |
---|---|---|
28/05/24 | 3.37 | -3.82% |
27/05/24 | 3.504 | -4.16% |
24/05/24 | 3.656 | +3.16% |
23/05/24 | 3.544 | +6.24% |
22/05/24 | 3.336 | +1.03% |
Delayed Quote Deutsche Boerse AG, May 28, 2024 at 07:02 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.37% | 63.85B | |
-2.45% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.52% | 26.52B | |
-21.44% | 18.69B | |
+2.79% | 12.73B | |
+22.07% | 12.11B | |
+27.74% | 12.07B |
- Stock Market
- Equities
- HNSA Stock
- 24H Stock